Skip to main content
Elekta logo

Elekta — Investor Relations & Filings

Ticker · EKTA ISIN · SE0000163628 LEI · 54930044O54BK617EP80 ST Manufacturing
Open in API
Filings indexed 1,124 across all filing types
Latest filing 2014-09-11 Board/Management Inform…
Country SE Sweden
Listing ST EKTA

About Elekta

https://www.elekta.com/

Elekta is a company specializing in precision radiation medicine. It develops and provides clinical solutions, including equipment and software, for treating cancer and brain disorders. The company's portfolio features linear accelerators, the Elekta Unity MR-Linac system, Leksell Gamma Knife for stereotactic radiosurgery, and comprehensive brachytherapy solutions. Elekta also offers oncology informatics software to support treatment planning and clinical workflow. A key focus is advancing adaptive radiotherapy, a personalized approach that utilizes real-time imaging to precisely target tumors and minimize exposure to healthy tissue, aiming to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Elekta utvecklar sin internrevision- och compliance funktion
Board/Management Information Classification · 1% confidence The document is a press release dated September 11, 2014, announcing the appointment of two key personnel: Heléne Vibbleus as the new Chief Audit Executive and Caroline Mofors as Group Compliance Officer. This directly relates to changes in senior management and board-related functions (audit and compliance reporting directly to the board). This aligns perfectly with the definition for Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2014-09-11 Swedish
Elekta strengthens its internal audit and compliance functions
Board/Management Information Classification · 1% confidence The document is a short press release announcing the appointment of two key personnel: a new Chief Audit Executive (Helene Vibbleus) and a new Group Compliance Officer (Caroline Mofors). This directly relates to changes in senior management and board oversight functions. Based on the provided definitions, the category 'Board/Management Information (Code: MANG)' is the most appropriate fit, as it covers 'Announcement of changes in the company's board of directors or senior management.' The document is not a full financial report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), but a specific personnel announcement.
2014-09-11 English
Elektas strålbehandlingssystem Versa HD tillgängligt i Japan
Regulatory Filings Classification · 1% confidence The document is a press release announcing that Elekta's Versa HD radiation therapy system has received clearance from the Japanese health authority. It contains product news, market expansion details, supporting statistics, executive quotes, and contact information for corporate communications and investor relations. Crucially, it concludes with a statement indicating that the information is being made public according to financial instrument laws, which is typical for regulatory disclosures or news that impacts investors. Since it is not a formal financial report (like 10-K or IR), nor a transcript (CT), nor a specific shareholder action (DIV, DVA), nor a management discussion (MDA), it best fits the general category for official regulatory announcements that are not otherwise specified. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a broad category for official company news releases impacting the market.
2014-09-02 Swedish
Elekta’s Versa HD radiation therapy system now available for treatment of cancer patients in Japan
Regulatory Filings Classification · 1% confidence The document is a press release announcing that Elekta's Versa HD radiation therapy system received clearance from Japan's Ministry of Health, Labor and Welfare. It contains product news, market context (cancer statistics in Japan), quotes from management, and contact information for Investor Relations and Corporate Communications. Crucially, the final paragraph states: "The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act." This indicates it is a formal regulatory disclosure intended for the public market, but it is not a standard financial report (like 10-K or IR) or a specific corporate action filing (like DIV or SHA). Given its nature as a general, market-sensitive announcement that doesn't fit the other specific categories (like M&A, Director's Dealing, or Earnings Release), it best fits the 'Regulatory Filings' fallback category (RNS), which covers general regulatory announcements.
2014-09-02 English
Enhanced collaboration with Toshiba strengthens Elekta’s position in Japan
Regulatory Filings Classification · 1% confidence The document announces a specific business development: an enhanced distribution agreement between Elekta Japan and Toshiba Medical Systems Corporation regarding linear accelerator sales. This is a material event concerning business operations and strategic partnerships, not a standard periodic financial report (like 10-K or IR), a management change (MANG), or a shareholder vote result (DVA). It is a specific corporate announcement. Since it details a significant business transaction/agreement that impacts future operations and market position, it fits best under the general category of a significant corporate event announcement. Given the provided definitions, this type of strategic business update, which is not explicitly covered by M&A (TAR) or Financing (CAP), is most appropriately classified as a general Regulatory Filing (RNS) or potentially a Legal/Contractual update (LTR), although LTR usually implies litigation. As it is a press release detailing a material business agreement, RNS (Regulatory Filings/Miscellaneous Announcements) is the most suitable fallback category for specific, non-standard corporate news releases.
2014-09-01 English
Utökat samarbete med Toshiba stärker Elektas position i Japan
Regulatory Filings Classification · 1% confidence The document is a press release written in Swedish announcing an expanded distribution agreement between Elekta Japan and Toshiba Medical Systems regarding linear accelerators. It details a strategic business development, partnership expansion, and future plans for customer support and market positioning. This type of announcement, which details strategic business moves, partnerships, or significant operational updates that are not standard financial reports (10-K, IR, ER) or mandatory regulatory filings (like insider trades or dividend notices), typically falls under general corporate news or regulatory disclosure. Since it is a formal announcement of a business development and includes contact information for Investor Relations and Corporate Communications, and is dated with a time stamp indicating public disclosure, it is best classified as a general Regulatory Filing (RNS) as it is a material, non-standard announcement that doesn't fit the more specific categories like M&A (TAR) or Capital Change (CAP). Given the short length (3096 chars) and the nature of the content (a press release announcing a deal), RNS is the most appropriate fallback for significant, non-financial-reporting news.
2014-09-01 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.